[CLINICAL EXPERIENCE WITH CENTROPHENOXINE (T-119) IN INTERNAL MEDICINE].
D000690:Amyotrophic Lateral Sclerosis; D035843:Biomedical Research; D001927:Brain Diseases; D000697:Central Nervous System Stimulants; D002561:Cerebrovascular Disorders; D002648:Child; D003919:Diabetes Insipidus; D004358:Drug Therapy; D004569:Electroencephalography; D005853:Geriatrics; D005951:Glucose Tolerance Test; D006501:Hepatic Encephalopathy; D007018:Hypopituitarism; D007388:Internal Medicine; D002504:Meclofenoxate; D014116:Toxicology; D014549:Urinary Incontinence
D000697:Central Nervous System Stimulants; D002504:Meclofenoxate
AMYOTROPHIC LATERAL SCLEROSIS; ANALEPTICS; BRAIN DISEASES; CEREBROVASCULAR DISORDERS; CHILD; CLINICAL RESEARCH; DIABETES INSIPIDUS; DRUG THERAPY; ELECTROENCEPHALOGRAPHY; GERIATRICS; GLUCOSE TOLERANCE TEST; HEPATIC COMA; HYPOPITUITARISM; TOXICOLOGIC REPORT; URINARY INCONTINENCE